Charité 2019-nCoV BHQ™ ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.
- Fast delivery: Product ships in 5 to 7 business days, additional 2-3 business days for EMEA and APAC orders
- Gold standard quencher: From the trusted inventor and original source of Black Hole Quencher™ (BHQ™) technology referenced in 7 of 8 WHO protocols
- Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production.
|Charite RdRP_SARSr Pan Sarbeco FAM-BHQ Probe||FAM-CCAGGTGGWACRTCATCMGGTGATGC-BHQ1|
|Charite RdRP_SARSr 2019-nCoV FAM-BHQ Probe||FAM-CAGGTGGAACCTCATCAGGAGATGC-BHQ1|
|Charite RdRP_SARSr Forward Primer||GTGARATGGTCATGTGTGGCGG|
|Charite RdRP_SARSr Reverse Primer||CARATGTTAAASACACTATTAGCATA|
|Charite E_Sarbeco FAM-BHQ Probe||FAM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ1|
|Charite E_Sarbeco Forward Primer||ACAGGTACGTTAATAGTTAATAGCGT|
|Charite E_Sarbeco Reverse Primer||ATATTGCAGCAGTACGCACACA|